MESALAMINE Reviews (MESALAMINE)Average Rating: 3.6 (3 Ratings)Filter ResultsCompare MESALAMINE with similar:
Type: Rx Drug
|
Results are sorted by Date added. Key to Ratings: 1=LOW (I would not recommend taking this medicine.) Page: 1 |
RATING | REASON | SIDE EFFECTS FOR MESALAMINE | COMMENTS | SEX | AGE | DURATION/ DOSAGE | DATE ADDED |
5 | Ulcerative colitis | I used lialda four 1.2 grams a day for many years, along w canasa suppositories. When lialda became generic i switched to it. For the last 6-8 years i m down to two 1.2 grams a day and no canasa. My colitis is totally controlled. | F | 67 | 25 years 1.2 grams 4X day | 11/25/2023 | 5 | Crohns | When I first started taking the drug it gave me ringing in my ears but that went away after about 3 weeks. It works in controlling Crohns. I usually only take it when I am first expiriencing a flare up and I stay on it until I am back in remission and then I stop taking it. | M | 54 | 20 years 4.8gm 1X day | 9/15/2023 | 1 | Crohns | Intense shaking, fever of 104, sweats. My wife brought me to the ER on day 10. I was admitted immediately. Was in the hospital for 4 days. They still were not sure what it was and told me to take it on Friday morning to see if I had another reaction. I took it Friday morning and ended up back in the hospital for another three days. Was tested for covid 3 times - negative. Finally was told it was a severe reaction to mesalamine. | Was told to take 4-.375g every morning. | M | 59 | 10 days .375g 1X day | 10/18/2020 |
MESALAMINE (MESALAMINE): Mesalamine (also known as 5-aminosalicylic acid) is used to treat certain types of bowel disease (distal ulcerative colitis, proctosigmoiditis, proctitis). It does not cure these conditions, but it may relieve mild-to-moderate pain and decrease the frequency of diarrhea/bloody stools caused by irritation/swelling in the colon/rectum. Mesalamine is an aminosalicylate anti-inflammatory drug. It is believed to work by blocking the production of certain natural chemicals that may cause pain and swelling. FDA Approval Date: 2004-09-17 (Sources: U.S. Centers for Medicare Services, FDA)